These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 38727195)

  • 1. Survivin, β-catenin, and ki-67 immunohistochemical expression in canine perivascular wall tumors: Preliminary assessment of prognostic significance.
    Godizzi F; Armando F; Boracchi P; Avallone G; Stefanello D; Ferrari R; Chiti LE; Cappelleri A; Zamboni C; Dell'Aere S; Corradi A; Roccabianca P
    Vet Pathol; 2024 Nov; 61(6):912-927. PubMed ID: 38727195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical investigation of cell cycle and apoptosis regulators (survivin, β-catenin, p53, caspase 3) in canine appendicular osteosarcoma.
    Bongiovanni L; Mazzocchetti F; Malatesta D; Romanucci M; Ciccarelli A; Buracco P; De Maria R; Palmieri C; Martano M; Morello E; Maniscalco L; Della Salda L
    BMC Vet Res; 2012 Jun; 8():78. PubMed ID: 22686277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survivin and related proteins in canine mammary tumors: immunohistochemical expression.
    Bongiovanni L; Romanucci M; Malatesta D; D'Andrea A; Ciccarelli A; Della Salda L
    Vet Pathol; 2015 Mar; 52(2):269-75. PubMed ID: 24686389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Canine cutaneous melanocytic tumours: significance of β-catenin and survivin immunohistochemical expression.
    Bongiovanni L; D'Andrea A; Porcellato I; Ciccarelli A; Malatesta D; Romanucci M; Della Salda L; Mechelli L; Brachelente C
    Vet Dermatol; 2015 Aug; 26(4):270-e59. PubMed ID: 25962968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic relevance of survivin in pancreatic endocrine tumors.
    Ekeblad S; Lejonklou MH; Stålberg P; Skogseid B
    World J Surg; 2012 Jun; 36(6):1411-8. PubMed ID: 22089920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uterine leiomyosarcoma management, outcome, and associated molecular biomarkers: a single institution's experience.
    Lusby K; Savannah KB; Demicco EG; Zhang Y; Ghadimi MP; Young ED; Colombo C; Lam R; Dogan TE; Hornick JL; Lazar AJ; Hunt KK; Anderson ML; Creighton CJ; Lev D; Pollock RE
    Ann Surg Oncol; 2013 Jul; 20(7):2364-72. PubMed ID: 23334251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic utility of apoptosis index, Ki-67 and survivin expression in dogs with nasal carcinoma treated with orthovoltage radiation therapy.
    Fu DR; Kato D; Watabe A; Endo Y; Kadosawa T
    J Vet Med Sci; 2014 Nov; 76(11):1505-12. PubMed ID: 25452259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical expression of β-catenin, Ki67, CD3 and CD18 in canine colorectal adenomas and adenocarcinomas.
    Herstad KMV; Gunnes G; Rørtveit R; Kolbjørnsen Ø; Tran L; Skancke E
    BMC Vet Res; 2021 Mar; 17(1):119. PubMed ID: 33712002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Canine mast cell tumors: correlation of apoptosis and proliferation markers with prognosis.
    Scase TJ; Edwards D; Miller J; Henley W; Smith K; Blunden A; Murphy S
    J Vet Intern Med; 2006; 20(1):151-8. PubMed ID: 16496935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic importance of survivin, Ki-67, and topoisomerase IIα in ovarian carcinoma.
    Kucukgoz Gulec U; Gumurdulu D; Guzel AB; Paydas S; Seydaoglu G; Acikalin A; Khatib G; Zeren H; Vardar MA; Altintas A
    Arch Gynecol Obstet; 2014 Feb; 289(2):393-8. PubMed ID: 23974278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic impact of Ki-67 in canine splenic hemangiosarcoma: A preliminary study.
    Brigandì E; Valenti P; Bacci B; Brunetti B; Avallone G
    Vet Pathol; 2024 Jul; 61(4):534-540. PubMed ID: 38214328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The study of the expression and the prognostic value of Survivin and Ki67 in pancreatic endocrine tumors].
    Liu WW; Zheng Y; Xia ZL; Zhang SQ; Bao F; Lin ZM; Ji XH; Ying LL; Zhao LL; Xu MF; Cai Guo-Ping ; Chen GR
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2015 Jan; 31(1):72-5. PubMed ID: 26016245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysregulation of the Wnt/beta-catenin signaling pathway in canine cutaneous melanotic tumor.
    Han JI; Kim DY; Na KJ
    Vet Pathol; 2010 Mar; 47(2):285-91. PubMed ID: 20139375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Canine perivascular wall tumors: high prognostic impact of site, depth, and completeness of margins.
    Avallone G; Boracchi P; Stefanello D; Ferrari R; Rebughini A; Roccabianca P
    Vet Pathol; 2014 Jul; 51(4):713-21. PubMed ID: 24048324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of nuclear survivin expression in resected adenoid cystic carcinoma of the head and neck.
    Ko YH; Roh SY; Won HS; Jeon EK; Hong SH; Lee MA; Kang JH; Hong YS; Kim MS; Jung CK
    Head Neck Oncol; 2010 Oct; 2():30. PubMed ID: 21034499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ki-67 and PCNA Expression in Canine Mammary Tumors and Adjacent Nonneoplastic Mammary Glands: Prognostic Impact by a Multivariate Survival Analysis.
    Carvalho MI; Pires I; Prada J; Lobo L; Queiroga FL
    Vet Pathol; 2016 Nov; 53(6):1138-1146. PubMed ID: 27162119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low Merlin expression and high Survivin labeling index are indicators for poor prognosis in patients with malignant pleural mesothelioma.
    Meerang M; Bérard K; Friess M; Bitanihirwe BK; Soltermann A; Vrugt B; Felley-Bosco E; Bueno R; Richards WG; Seifert B; Stahel R; Weder W; Opitz I
    Mol Oncol; 2016 Oct; 10(8):1255-65. PubMed ID: 27378628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the Wnt/β-catenin signaling pathway and CTNNB1 mutations in canine intestinal epithelial proliferative lesions.
    Ishikawa K; Chambers JK; Uchida K
    J Vet Med Sci; 2024 Jul; 86(7):748-755. PubMed ID: 38811188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear survivin is a powerful novel prognostic marker in gastroenteropancreatic neuroendocrine tumor disease.
    Grabowski P; Griss S; Arnold CN; Hörsch D; Göke R; Arnold R; Heine B; Stein H; Zeitz M; Scherübl H
    Neuroendocrinology; 2005; 81(1):1-9. PubMed ID: 15809513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-catenin and survivin expression in keratocystic odontogenic tumor (KCOT). A comparative immunohistochemical study in primary, recurrent and nevoid basal cell carcinoma syndrome (NBCCS)-associated lesions.
    Leonardi R; Matthews JB; Loreto C; Musumeci G; Campisi G; Lo Muzio L; dos Santos JN; Pastorino L; Bufo P; Pannone G
    Histol Histopathol; 2013 Sep; 28(9):1175-84. PubMed ID: 23572266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.